Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STARS: Step-up vs Step-down Strategies in Childhood Arthritis
NCT03728478Phase 3Recruiting
- Sponsor
- Istituto Giannina Gaslini
- Start
- May 2019
- Primary completion
- Feb 2025
- Countries
- 1
01
Overview
A Phase 3 trial of etanercept in juvenile idiopathic arthritis (JIA), sponsored by Istituto Giannina Gaslini. Started May 2019; status: recruiting.
02
Drugs
etanercept
03
Conditions
juvenile idiopathic arthritis (JIA)
Beyond the preview
Go deeper on NCT03728478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03728478.